Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake
Risk of Stroke Skyrockets with COVID-19 Infection after Vaccination
Breakthrough within 21 Days of Shot Confers 8-Fold Risk of Ischemic Stroke
By Peter A. McCullough, MD, MPH
Because the COVID-19 vaccines load the body with the genetic code for the thrombogenic and lethal Wuhan Spike protein, those who take a vaccine are vulnerable to a catastrophe if they get infected with SARS-CoV-2 after recently taking one of the shots.
Nahab and coworkers from Emory analyzed a statewide database of COVID-19 vaccine recipients. Approximately 5 million adult Georgians received at least one COVID-19 vaccine between December 2020 and March 2022: 54% received BNT162b2, 41% received mRNA-1273, and 5% received Ad26.COV2.S. Those with concurrent COVID-19 infection within 21 days post-vaccination had an increased risk of ischemic (OR = 8.00, 95% CI: 4.18, 15.31) and hemorrhagic stroke (OR =5.23, 95% CI: 1.11, 24.64).
This analysis shows one of many great dangers present in rapid vaccine development and rollout without sufficient data safety and monitoring. Stroke is a devastating outcome and it appears that a large number of debilitating cases could have been avoided if the COVID-19 vaccines were taken off the market in January, 2021 for excess mortality. The patients in this study would have been spared stroke and disability.
These data highlight the need for Spike protein detoxification, in other words, methods to reduce the burden of Spike protein within the body. We have a widely anticipated manuscript in press featuring an ambulatory triple combination regimen of nattokinase, bromelain, and curcumin which works proteolytically clear Spike while providing a low level of thrombolysis and control over inflammation.
Subscribe to Courageous Discourse as we bring you the truth.
Supported in part by the McCullough Foundation
Nahab F, Bayakly R, Sexton ME, Lemuel-Clarke M, Henriquez L, Rangaraju S, Ido M. Factors associated with stroke after COVID-19 vaccination: a statewide analysis. Front Neurol. 2023 Jun 28;14:1199745. doi: 10.3389/fneur.2023.1199745. PMID: 37448752; PMCID: PMC10337778.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.